Christophe Mossé appointed as CEO of Arkopharma group
He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Horus Pharma accelerates its international expansion across 8 new countries
- Health Afterwork in Nice: connecting innovators in the HealthTech sector
- Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation
- Klava Innovation and Isis Medical: a partnership serving respiratory health
- Nice awarded the “Ma Ville se Ligue” label for its health prevention policy
- Investment: Sedna Santé lays the foundation stone for a new clinic in Nice
- Team Nice Côte d’Azur at Bio International Convention 2025 : Smart Pipelines and Global Partnerships
- Nice welcomes its first faculty of pharmacy: a major step forward for health education on the Côte d’Azur.
- Team Nice Côte d’Azur at Viva Technology 2025: at the heart of technological transitions and international attractiveness
- Nice Côte d’Azur: health as a driver of territorial innovation
